4//SEC Filing
Zeskind Benjamin J. 4
Accession 0001415889-22-003324
CIK 0001790340other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 4:39 PM ET
Size
5.8 KB
Accession
0001415889-22-003324
Insider Transaction Report
Form 4
Immuneering CorpIMRX
Zeskind Benjamin J.
DirectorPRESIDENT AND CEO10% Owner
Transactions
- Purchase
Class A Common Stock
2022-03-23$8.02/sh+3,000$24,060→ 2,257,352 total
Holdings
- 894,927(indirect: See Foonote)
Class A Common Stock
Footnotes (2)
- [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $7.92 to $8.10. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares acquired at each price.
- [F2]Held by the Benjamin J. Zeskind 2020 Family Trust, where Lisa Schwartz, Dr. Zeskind's spouse, serves as sole trustee.
Documents
Issuer
Immuneering Corp
CIK 0001790340
Entity typeother
Related Parties
1- filerCIK 0001870062
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 4:39 PM ET
- Size
- 5.8 KB